The FDA identified deficiencies in the company’s application and declined to approve the drug. Tlando is a testosterone undecanoate specially formulated to be absorbed orally. It is meant to be taken daily. Normally oral testosterone is destroyed by the liver, this formulation bypasses the liver. More information is available on the usual financial news sites (they watch the company’s stock) including this article.